Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Entrada Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Abeona Therapeutics Inc. June 12, 202694.7%
-
Entrada Therapeutics Inc. June 10, 202692.0%
-
Amylyx Pharmaceuticals Inc. June 5, 202564.0%
-
Entrada Therapeutics Inc. June 7, 202399.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 20, 2026 | Entrada Therapeutics Inc. | Open-market purchase | +5,000 | $5.86 | $29,300 |
| Jan 26, 2026 | Abeona Therapeutics Inc. | Grant or award | +37,313 | — | — |
| Mar 20, 2025 | Amylyx Pharmaceuticals Inc. | Open-market purchase | +10,000 | $3.70 | $37,000 |
| Jan 31, 2025 | Abeona Therapeutics Inc. | Grant or award | +36,101 | — | — |
| Aug 13, 2024 | Abeona Therapeutics Inc. | Grant or award | +11,044 | — | — |
Questions about Bernhardt G. Zeiher
What boards is Bernhardt G. Zeiher on?
Bernhardt G. Zeiher sits on the boards of Abeona Therapeutics Inc., Amylyx Pharmaceuticals Inc. and Entrada Therapeutics Inc.
How long has Bernhardt G. Zeiher served on boards?
Our records show at least 9 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.